Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry

Prenatal Diagnosis

Volumn 28, Issue 3, 2008, Pages 203-208

  Li, Ying ^a   Finning, Kirstin ^b   Daniels, Geoff ^b   Hahn, Sinuhe ^a   Zhong, Xiaoyan ^a   Holzgreve, Wolfgang ^a  

^a UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Cell free fetal DNA; KEL1 genotyping; MALDI TOF mass spectrometry; Prenatal diagnosis

Indexed keywords

CELL FREE FETAL DNA; DNA; UNCLASSIFIED DRUG;

ADULT; ALLELE; ALLOIMMUNIZATION; AMNION CELL; ANTIGEN DETECTION; ARTICLE; BLOOD GROUP KELL SYSTEM; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; FALSE POSITIVE RESULT; FEMALE; GENE; GENOTYPE; HEMOLYTIC ANEMIA; HUMAN; HUMAN TISSUE; KEL1 GENE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR BIOLOGY; NON INVASIVE MEASUREMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERODIAGNOSIS; SINGLE ALLELE BASED EXTENSION REACTION; UMBILICAL CORD BLOOD;

DNA; FEMALE; FETAL BLOOD; GENOTYPE; HUMANS; KELL BLOOD-GROUP SYSTEM; MASS SPECTROMETRY; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; SENSITIVITY AND SPECIFICITY;

EID: 41149159604     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1936     Document Type: Article

References (21)

1. Chiu RW, Lau TK, Leung TN, et al. 2002. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 360: 998-1000.
2. Chow KC, Chiu RW, Tsui NB, et al. 2007. Mass Spectrometry detection of an SNP panel as an internal positive control for fetal DNA analysis in maternal plasma. Clin Chem 53: 141-142.
3. Daniels G, Finning K, Martin P, Summers J. 2006. Fetal blood group genotyping: present and future. Ann N Y Acad Sci 1075: 88-95.
4. Ding C, Cantor CR. 2003. Direct molecular haplotyping of long-range genomic DNA with M1-PCR. Proc Natl Acad Sci U S A 100: 7449-7453.
5. Ding C, Chiu RW, Lau TK, et al. 2004. MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. Proc Natl Acad Sci U S A 101: 10762-10767.
6. Finning K, Martin P, Summers J, Daniels G. 2007. Fetal genotyping for the K (Kell) and RhC, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion 47: 2126-2133.
7. Hahn S, Holzgreve W. 2002. Prenatal diagnosis using fetal cells and cell-free fetal DNA in maternal blood: what is currently feasible? Clin Obstet Gynecol 45: 649-656.
8. Huang DJ, Zimmermann BG, Holzgreve W, Hahn S. 2005. Use of an automated method improves the yield and quality of cell-free fetal DNA extracted from maternal plasma. Clin Chem 51: 2419-2420.
9. Jackson LG, Zachary JM, Fowler SE, et al. 1992. A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. N Engl J Med 327: 594-598.
10. Lee S, Naime DS, Reid ME, Redman CM. 1997. Molecular basis for the high-incidence antigens of the Kell blood group system. Transfusion 37: 1117-1122.
11. Lee S, Wu X, Reid ME, Zelinski T, Redman C. 1995. Molecular basis of the Kell (K1) phenotype. Blood 85: 912-9126.
12. Li Y, Holzgreve W, Kiefer V, Hahn S. 2006a. Maldi-tof mass spectrometry compared with real-time PCR for detection of fetal cell-free DNA in maternal plasma. Clin Chem 52: 2311-2312.
13. Li Y, Wenzel F, Holzgreve W, Hahn S. 2006b. Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation. Electrophoresis 27: 3889-3896.
14. Li Y, Page-Christiaens GC, Gille JJ, Holzgreve W, Hahn S. 2007. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn 27: 11-17.
15. Li Y, Zimmermann B, Rusterholz C, et al. 2004. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 50: 1002-1011.
16. Li Y, Di Naro E, Vitucci A, et al. 2005. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 293: 843-849.
17. Lo YM, Corbetta N, Chamberlain PF, et al. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487.
18. Lo YM, Hjelm NM, Fidler C, et al. 1998. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339: 1734-1738.
19. Lo YM, Tsui NB, Chiu RW, et al. 2007. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 13: 218-223.
20. Spence WC, Maddalena A, Demers DB, Bick DP. 1997. Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies. J Reprod Med 42: 353-357.
21. Zhong XY, Burk MR, Troeger C, Jackson LR, Holzgreve W, Hahn S. 2000. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 20: 795-798.